miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis
Future Oncology · 2024
DOI: 10.2217/fon-2023-0922 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Future Oncology, 2024. Verfasst von Jiajin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Early Detection of Cancer, MicroRNAs, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
This study aimed to systematically evaluate the value of miRNA-143 in the early detection of bladder cancer (BCa).
Methods
CNKI, WanFang, PubMed and Wiley Online Library databases were explored according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. A random-effects model was used to obtain pooled sensitivity, specificity and other related indicates.
Results
Six studies were included for analysis. The overall pooled sensitivity and specificity were 0.80 (95% CI: 0.74-0.85) and 0.85 (95% CI: 0.78-0.91), and the area under the curve was 0.88 (95% CI: 0.85-0.91). Coupled with miR-100, it showed better diagnostic power (area under the curve: 0.95). Conclusion: miRNA-143 may serve as a promising noninvasive tool for the early detection of BCa. Bladder cancer (BCa) is a common and deadly malignant tumor worldwide; however, noninvasive diagnosis can significantly improve the prognosis of patients. Recently, miRNAs have emerged as potential diagnostic biomarkers for BCa. Among them, miRNA-143 has shown promising results in several studies. This meta-analysis aimed to evaluate the overall diagnostic accuracy of miRNA-143 for BCa through a systematic review and meta-analysis of six published articles. Excitingly, the results of this meta-analysis suggest that miRNA-143 has potential diagnostic value in BCa. Particularly, miRNA-143 combined with miRNA-100 maintained better competence. Besides, miRNA-143 in plasma exhibited better diagnostic strength than that in urine. The authors believe that their study provides valuable insights into the use of miRNA-143 as a diagnostic biomarker for BCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Public Health, Southern Medical University, No.1023, ShaTai South Road, Guangzhou City, Guangdong Province, 510515, China.
ORCID-Profile: Jufeng Ye
Zitieren
APA
Li, J., Li, H., Yang, Y., Sen, Y., & Ye, J. (2024). miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis. Future Oncology. https://doi.org/10.2217/fon-2023-0922
Vancouver
Li J, Li H, Yang Y, Sen Y, Ye J. miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis. Future Oncology. 2024. doi:10.2217/fon-2023-0922
BibTeX
@article{Li2024,
author = {Li, Jiajin and Li, Haonan and Yang, Yutao and Sen, Yu and Ye, Jufeng},
title = {miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis},
journal = {Future Oncology},
year = {2024},
doi = {10.2217/fon-2023-0922}
}
EUVIMED